Virology: Delta variant partially able to escape antibody neutralization
Nature
July 8, 2021
The Delta variant of SARS-CoV-2 is resistant to some of the laboratory-made monoclonal antibodies, and less inhibited by antibodies in the sera of individuals who were previously infected with SARS-CoV-2 or individuals who received one dose of either the Pfizer–BioNTech or AstraZeneca vaccine. The findings are published online in Nature this week. However, the paper reports that a neutralizing response is generated against the Delta variant after two doses of the respective vaccines.
Olivier Schwartz and colleagues investigated how reactive monoclonal antibodies and antibodies in blood sera from 103 individuals with a previous SARS-CoV-2 infection and 59 recent vaccine recipients were against the Delta variant, compared with the Alpha and Beta variants, and a reference variant that is more similar to earlier strains of SARS-CoV-2. The authors found that some monoclonal antibodies — including the treatment bamlanivimab — were unable to bind to the spike protein of the Delta variant, which prevented these monoclonal antibodies from neutralizing the virus. The findings suggest that the Delta variant manages to escape antibodies that target certain parts of the spike protein.
The authors also showed that the Delta variant was fourfold less sensitive than the Alpha variant to sera collected from individuals who had recovered from COVID-19 up to 12 months after SARS-CoV-2 infection. A single dose of either the Pfizer–BioNTech or the AstraZeneca COVID-19 vaccines was poorly or not at all efficient against the Beta and Delta variants; only about 10% of individuals were able to neutralize the Delta variant after one dose. However, administration of a second dose of either vaccine generated a neutralizing response in 95% of the individuals, although the antibodies were found to be three-to-fivefold less potent against the Delta variant than the Alpha variant. The authors also found that vaccination of individuals with a previous SARS-CoV-2 infection boosted immunity above the threshold for neutralization of the variant.
doi:10.1038/s41586-021-03777-9
Research highlights
-
Mar 24
Zoology: Numerical abilities may be hardwired in newly-hatched zebrafishCommunications Biology
-
Mar 23
Ecology: Australian reef species decline following decade of warmingNature
-
Mar 23
Astronomy: Explaining the acceleration of the interstellar object ‘OumuamuaNature
-
Mar 23
Neuroscience: How bird brain cells work in harmony to start singingNature
-
Mar 22
Astronomy: Nucleic acid precursor detected on RyuguNature Communications
-
Mar 21
Ecology: Inbreeding may hamper killer whale conservationNature Ecology & Evolution